 INmune Bio NASDAQ:INMB and Applied Genetic Technologies NASDAQ:AGTC are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends. Risk Volatility INmune Bio has a beta of 2.42, suggesting that its share ... 